FeesSafety
Pluang+

Jinko Holdings to release Q3 2026 earnings on Oct 30 with a live conference call.

Company Fundamentals
23 Oct 2026
PRNewsWire
View Source
Neutral
Jinko Holdings to release Q3 2026 earnings on Oct 30 with a live conference call.

Jinko Holdings Limited announced it will release its unaudited financial results for Q3 2026 on October 30 before U.S. markets open. The company will hold a live earnings conference call the same day at 8:30 a.m. U.S. Eastern Time to discuss the results. Investors can register online to participate, and a replay will be available until November 6. This update is important as it provides insight into Jinko's performance in the renewable energy sector and its strategic investments.

Jinko Holdings' upcoming Q3 2026 results provide context for energy sector activity on Pluang. As of Oct 23, 2026 17:21 WIB, 51 of 79 priced Energy-sector US stocks rose while 19 fell. Notable movers include UGP at USD 7.98 with a 1-day change of +2.31%, Williams Companies Inc at USD 72.15 with +2.15%, and Suncor Energy Inc. at USD 79.00 with +2.05%.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
19 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App